What is the share price of Remedium Lifecare Ltd (REMLIFE) today?
The share price of REMLIFE as on 20th June 2025 is ₹0.92. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Remedium Lifecare Ltd (REMLIFE) share?
The past returns of Remedium Lifecare Ltd (REMLIFE) share are- Past 1 week: -16.51%
- Past 1 month: -46.47%
- Past 3 months: -37.53%
- Past 6 months: -74.70%
- Past 1 year: -92.36%
- Past 3 years: 7.75%
- Past 5 years: 566.47%
What are the peers or stocks similar to Remedium Lifecare Ltd (REMLIFE)?
The peers or stocks similar to Remedium Lifecare Ltd (REMLIFE) include:What is the market cap of Remedium Lifecare Ltd (REMLIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remedium Lifecare Ltd (REMLIFE) is ₹83.79 Cr as of 20th June 2025.What is the 52 week high and low of Remedium Lifecare Ltd (REMLIFE) share?
The 52-week high of Remedium Lifecare Ltd (REMLIFE) is ₹15.13 and the 52-week low is ₹0.87.What is the PE and PB ratio of Remedium Lifecare Ltd (REMLIFE) stock?
The P/E (price-to-earnings) ratio of Remedium Lifecare Ltd (REMLIFE) is 39.34. The P/B (price-to-book) ratio is 1.95.Which sector does Remedium Lifecare Ltd (REMLIFE) belong to?
Remedium Lifecare Ltd (REMLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Remedium Lifecare Ltd (REMLIFE) shares?
You can directly buy Remedium Lifecare Ltd (REMLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Remedium Lifecare Ltd
REMLIFE Share Price
0.921.10% (+0.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
REMLIFE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
REMLIFE Performance & Key Metrics
REMLIFE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.95 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.65 | 6.55 | 0.83% |
REMLIFE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
REMLIFE Company Profile
Remedium Lifecare Ltd is a pharmaceutical company engaged in trading and manufacturing active pharmaceutical ingredients (APIs) and intermediates for domestic and international markets, including regulated markets.
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
13.20%
13.20%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
22.95
22.95
1Y Return
2.92%
2.92%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
19.32
19.32
1Y Return
10.98%
10.98%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
10.81%
10.81%
Buy Reco %
72.00
72.00
MANKIND
PE Ratio
48.88
48.88
1Y Return
4.22%
4.22%
Buy Reco %
81.25
81.25
REMLIFE Forecast
REMLIFE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
REMLIFE
REMLIFE
Income
Balance Sheet
Cash Flow
Annual Normal View
REMLIFE Income Statement
REMLIFE Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.43 | 0.37 | 0.25 | 2.89 | 90.03 | 504.79 | 509.84 | 4,062.79 | 416.05 | — | ||||||||||
Raw Materials | 0.71 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 417.30 | 4,127.29 | 406.34 | — | ||||||||||
| Power & Fuel Cost | 0.08 | 0.02 | 0.00 | 0.05 | 0.07 | 0.09 | 0.06 | 0.06 | ||||||||||||
| Employee Cost | 0.04 | 0.13 | 0.04 | 0.18 | 0.19 | 0.21 | 0.55 | 0.40 | ||||||||||||
| Selling & Administrative Expenses | 0.13 | 0.05 | 0.00 | 0.47 | 1.09 | 3.76 | 6.46 | 4.95 | ||||||||||||
| Operating & Other expenses | 0.47 | 0.01 | 0.19 | 1.79 | 87.96 | 498.91 | 77.46 | -125.20 | ||||||||||||
EBITDA | 0.00 | 0.02 | 0.02 | 0.40 | 0.72 | 1.82 | 8.01 | 55.29 | 9.71 | — | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.07 | 0.15 | 0.06 | 0.04 | — | ||||||||||
| PBIT | 0.00 | 0.02 | 0.02 | 0.39 | 0.66 | 1.75 | 7.86 | 55.23 | 9.67 | — | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.23 | 0.45 | 4.78 | 5.29 | — | ||||||||||
| PBT | 0.00 | 0.02 | 0.02 | 0.38 | 0.64 | 1.52 | 7.41 | 50.45 | 4.38 | — | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.02 | 0.09 | 0.17 | 0.45 | 1.97 | 17.72 | 2.25 | — | ||||||||||
| Net Income | 0.00 | 0.02 | -0.00 | 0.29 | 0.47 | 1.07 | 5.44 | 32.73 | 2.13 | — | ||||||||||
| EPS | 0.00 | 0.00 | -0.00 | 0.01 | 0.01 | 0.02 | 0.09 | 1.03 | 0.03 | — | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
REMLIFE Company Updates
REMLIFE Stock Peers
REMLIFE Past Performance & Peer Comparison
REMLIFE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Remedium Lifecare Ltd | 39.34 | 1.95 | — |
| Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
| Cipla Ltd | 22.95 | 4.51 | 1.07% |
| Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
REMLIFE Stock Price Comparison
Compare REMLIFE with any stock or ETFCompare REMLIFE with any stock or ETF
REMLIFE
REMLIFE Holdings
REMLIFE Shareholdings
REMLIFE Promoter Holdings Trend
REMLIFE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
REMLIFE Institutional Holdings Trend
REMLIFE Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 17.78%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
REMLIFE Shareholding Pattern
REMLIFE Shareholding Pattern
REMLIFE Shareholding History
REMLIFE Shareholding History
Foreign Institutions
smallcases containing REMLIFE stock
smallcases containing REMLIFE stock
Looks like this stock is not in any smallcase yet.
REMLIFE Events
REMLIFE Events
REMLIFE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
REMLIFE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
REMLIFE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
REMLIFE has not given any dividends in last 5 years
REMLIFE Dividends
REMLIFE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeREMLIFE Stock News & Opinions
REMLIFE Stock News & Opinions
Articles & Videos
Earnings
Remedium Lifecare reports standalone net loss of Rs 2.64 crore in the March 2025 quarter
Net Loss of Remedium Lifecare reported to Rs 2.64 crore in the quarter ended March 2025 as against net loss of Rs 53.72 crore during the previous quarter ended March 2024. Sales declined 94.21% to Rs 81.57 crore in the quarter ended March 2025 as against Rs 1408.49 crore during the previous quarter ended March 2024. For the full year,net profit declined 95.33% to Rs 1.53 crore in the year ended March 2025 as against Rs 32.73 crore during the previous year ended March 2024. Sales declined 94.49% to Rs 222.50 crore in the year ended March 2025 as against Rs 4041.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales81.571408.49 -94 222.504041.71 -94 OPM %-1.45-2.49 --0.810.82 - PBDT-2.11-35.99 94 3.7050.51 -93 PBT-2.12-36.00 94 3.6650.45 -93 NP-2.64-53.72 95 1.5332.73 -95 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Remedium Lifecare announces board meeting date
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Remedium Lifecare to consider right Issue
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 24 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Remedium Lifecare to convene board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 7 April 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Remedium Lifecare standalone net profit declines 98.34% in the December 2024 quarter
Net profit of Remedium Lifecare declined 98.34% to Rs 0.76 crore in the quarter ended December 2024 as against Rs 45.82 crore during the previous quarter ended December 2023. Sales declined 97.92% to Rs 38.15 crore in the quarter ended December 2024 as against Rs 1834.18 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales38.151834.18 -98 OPM %-14.392.98 - PBDT1.0668.79 -98 PBT1.0568.78 -98 NP0.7645.82 -98 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Remedium Lifecare to convene board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Remedium Lifecare to convene board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 22 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Remedium Lifecare standalone net profit declines 72.74% in the September 2024 quarter
Net profit of Remedium Lifecare declined 72.74% to Rs 1.78 crore in the quarter ended September 2024 as against Rs 6.53 crore during the previous quarter ended September 2023. Sales declined 94.65% to Rs 25.08 crore in the quarter ended September 2024 as against Rs 468.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales25.08468.57 -95 OPM %17.781.35 - PBDT2.4710.42 -76 PBT2.4610.41 -76 NP1.786.53 -73 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Remedium Lifecare to declare Quarterly Result
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Remedium Lifecare postpones board meeting
Remedium Lifecare has postponed the meeting of the Board of Directors which was scheduled to be held on 3 September 2024. The meeting will now be held on 4 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 595.31%, vs industry avg of 9.03%
Over the last 5 years, market share increased from 0% to 1.07%